S. G. Wolfe

Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome

G. Dukes, J. Harding, L. Hamm, 1997, Alimentary pharmacology & therapeutics.

Transient Receptor Potential Vanilloid Type 4 Channel Expression in Chronic Rhinosinusitis

N. Cohen, Marcelo B. Antunes, B. Woodworth, 2008, American journal of rhinology.

Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy plus atezolizumab

I. Bondarenko, L. Hart, D. Spigel, 2019, Annals of Oncology.

Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients

M. Washington, C. Hunt, W. Chey, 2001, American Journal of Gastroenterology.

"Three day fever"; an acute febrile disease of childhood (further observations).

S. G. Wolfe, C. Webb, 1950, A M A Journal of Diseases of Children.

Alosetron, a 5HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients*

D. Drossman, M. Camilleri, E. Mayer, 1998 .